CHELSEA ELLINGSON HIPOLITO: Open Payments
NPI 1184273617 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 27 payments from 11 companies in 2025. Trend: 2023 $909 · 2024 $812 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| ABBVIE INC. | 6 | $149 |
| Amgen Inc. | 1 | $132 |
| Gilead Sciences, Inc. | 1 | $126 |
| PFIZER INC. | 3 | $76 |
| Hologic Sales and Service, LLC | 3 | $64 |
| ViiV Healthcare Company | 2 | $38 |
| Exact Sciences Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
| Philips North America LLC | 1 | $15 |
Products named: BREZTRI, QULIPTA, APTIMA, UBRELVY, AIRSUPRA, PAXLOVID, APRETUDE, ELIQUIS.
Industry payments across CA — which companies pay providers there.
